Published in

Nutrition Society, Proceedings of the Nutrition Society, 4(79), p. 388-403, 2020

DOI: 10.1017/s0029665120000129

Links

Tools

Export citation

Search in Google Scholar

PUFA and their derivatives in neurotransmission and synapses: a new hallmark of synaptopathies

Journal article published in 2020 by Mathieu Di Miceli ORCID, Clémentine Bosch-Bouju ORCID, Sophie Layé ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Orange circle
Published version: archiving restricted
Data provided by SHERPA/RoMEO

Abstract

PUFA of then-3 andn-6 families are present in high concentration in the brain where they are major components of cell membranes. The main forms found in the brain are DHA (22 :6,n-3) and arachidonic acid (20:4,n-6). In the past century, several studies pinpointed that modifications ofn-3 andn-6 PUFA levels in the brain through dietary supply or genetic means are linked to the alterations of synaptic function. Yet, synaptopathies emerge as a common characteristic of neurodevelopmental disorders, neuropsychiatric diseases and some neurodegenerative diseases. Understanding the mechanisms of action underlying the activity of PUFA at the level of synapses is thus of high interest. In this frame, dietary supplementation in PUFA aiming at restoring or promoting the optimal function of synapses appears as a promising strategy to treat synaptopathies. This paper reviews the link between dietary PUFA, synapse formation and the role of PUFA and their metabolites in synaptic functions.